Skip NavigationMarketsBusinessInvestingTechPoliticsVideoWatchlistInvesting Club
PRO
LivestreamMenu
Angelica Peebles is a CNBC Health and Pharmaceutical Reporter based at CNBC Global Headquarters in Englewood Cliffs, N.J.
read more
Latest
Eli Lilly’s top dealmaker says don’t be surprised to see more M&A that pushes Lilly into new areasAngelica Peebles40 Min Agowatch nowVIDEO09:18Lilly’s Van Naarden: Nothing is off the table for dealmakingAngelica Peebles45 Min Agowatch nowVIDEO06:02Watch CNBC’s full interview with Summit co-CEO Dr. Maky ZanganehAngelica PeeblesJune 1, 2026watch nowVIDEO03:20Moderna CEO Stephane Bancel on INT trial results: There’s duration of efficacy which is excitingAngelica PeeblesJune 1, 2026watch nowVIDEO05:11Revolution Medicines CEO Mark Goldsmith on new Pancreatic cancer drug breakthroughAngelica PeeblesJune 1, 2026watch nowVIDEO04:14Bristol Myers Squibb CEO on cancer developments in the pipelineAngelica PeeblesJune 1, 2026A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in ChinaAngelica PeeblesMay 31, 2026Replimune to resubmit twice-rejected drug for approval after FDA shakeupAngelica PeeblesMay 29, 2026watch nowVIDEO01:27FDA chief, head of vaccines and head of drug evaluation roles all under temporary leadershipAngelica PeeblesMay 18, 2026FDA shuffles top drug, biologics leaders in latest leadership shakeupAngelica PeeblesMay 15, 2026Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaborationAngelica PeeblesMay 15, 2026Biogen advances Alzheimer’s drug to late-stage trial despite disappointing dataAngelica PeeblesMay 14, 2026
About The Author
